DCGI clears Bharat Biotech's Covaxin for restricted emergency use in children aged 6-12 years
Bharat Biotech has been asked to submit safety data alongwith the data on adverse event with due analysis, every 15 days for the first two months and after that monthly data for up to five months
DCGI approves Bharat Biotech's Covaxin for restricted emergency use in children aged 6-12 years - ANI
The Drugs Controller General of India (DCGI) has on Tuesday given restricted emergency-use authorisation to Bharat Biotech's Covaxin for children between the age of 6 and 12.
DGCI has asked the Hyderabad-based vaccine manufacturing company - Bharat Biotech - to submit safety data alongwith the data on adverse event with due analysis, every 15 days for the first two months and after that monthly data for up to five months.
The no objection certificate was granted to Bharat Biotech after two-month long deliberations on the recommendation given by the Subject Expert Committee (SEC) on COVID-19 last week.
On 21 April, the SEC of DGCI had asked Bharat Biotech to provide additional data on administration of Covaxin for children among children between 2 and 12 years.
For the unversed, in December 2021, the panel had approved Covaxin for emergency use in children above 12 years.
Earlier in March, the Centre told the Delhi High Court that it will be filing a status report regarding the COVID-19 vaccination among children below 12 years of age.
DCGI has also granted emergency use authorisation to Corbevax for children between the age of 5-12 years.
Inputs from agencies
Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
also read
What we know about COVID-19 XE variant and how to protect ourselves from it
COVID-19 XE variant: With coronavirus is continuously mutating, the spread of new variants is not surprising
COVID-19: Govt panel recommends emergency use authorisation for Corbevax vaccine for 5-11 age group
Biological E's Corbevax is currently being used to inoculate children aged 12-14 years. It is India's first protein sub-unit COVID vaccine
COVID-19 update: India logs 949 new cases, 5.75% lower than a day ago; positivity rate up at 0.26%
The Ministry of Health and Family Welfare (MoHFW) informed that six people have died due to COVID-19 in the last 24 hours, taking total deaths due to the virus so far to 5,21,743